Radioresistance in Glioblastoma and the Development of Radiosensitizers
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Radioresistance in Glioblastoma and the Development of Radiosensitizers
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 9, Pages 2511
Publisher
MDPI AG
Online
2020-09-03
DOI
10.3390/cancers12092511
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma
- (2020) David A. Reardon et al. JAMA Oncology
- Radiotherapy resistance acquisition in Glioblastoma. Role of SOCS1 and SOCS3
- (2019) Maria Paz Ventero et al. PLoS One
- Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial
- (2019) Ulrich Herrlinger et al. LANCET
- Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging
- (2019) Anne Laprie et al. BMC CANCER
- Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair
- (2019) Jianhui Ma et al. CANCER CELL
- Acyl-CoA-Binding Protein Drives Glioblastoma Tumorigenesis by Sustaining Fatty Acid Oxidation
- (2019) Ceren Duman et al. Cell Metabolism
- Radiomics in Glioblastoma: Current Status and Challenges Facing Clinical Implementation
- (2019) Ahmad Chaddad et al. Frontiers in Oncology
- Dual blockage of STAT3 and ERK1/2 eliminates radioresistant GBM cells
- (2019) Bowen Xie et al. Redox Biology
- First-in-Human Phase I Clinical Trial of Pharmacologic Ascorbate Combined with Radiation and Temozolomide for Newly Diagnosed Glioblastoma
- (2019) Bryan G. Allen et al. CLINICAL CANCER RESEARCH
- Metabolic Abnormalities in Glioblastoma and Metabolic Strategies to Overcome Treatment Resistance
- (2019) Weihua Zhou et al. Cancers
- Radiomics-Based Machine Learning in Differentiation Between Glioblastoma and Metastatic Brain Tumors
- (2019) Chaoyue Chen et al. Frontiers in Oncology
- 425PCHLOROBRAIN phase IB trial: The addition of chloroquine, an autophagy inhibitor, to concurrent radiation and temozolomide for newly diagnosed glioblastoma
- (2019) I Compter et al. ANNALS OF ONCOLOGY
- IDH1‑R132H mutation radiosensitizes U87MG glioma cells via epigenetic downregulation of TIGAR
- (2019) Narui Yin et al. Oncology Letters
- Bevacizumab may improve quality of life, but not overall survival in glioblastoma: an epidemiological study
- (2018) D Gramatzki et al. ANNALS OF ONCOLOGY
- The pro-tumorigenic effects of metabolic alterations in glioblastoma including brain tumor initiating cells
- (2018) Catherine J. Libby et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Phase 2 Study of Bortezomib Combined With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Safety and Efficacy Assessment
- (2018) Xiao-Tang Kong et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Cancer Radiosensitizers
- (2018) Hao Wang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Identification of microRNAs differentially expressed in glioblastoma stem-like cells and their association with patient survival
- (2018) Jiri Sana et al. Scientific Reports
- Radiosensitization Effect of Talazoparib, a Parp Inhibitor, on Glioblastoma Stem Cells Exposed to Low and High Linear Energy Transfer Radiation
- (2018) Paul Lesueur et al. Scientific Reports
- The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models
- (2018) Stephen T. Durant et al. Science Advances
- IGFBP6 controls the expansion of chemoresistant glioblastoma through paracrine IGF2/IGF-1R signaling
- (2018) Claudia R. Oliva et al. Cell Communication and Signaling
- Exposure of Breast and Lung Cancer Cells to a Novel Estrone Analog Prior to Radiation Enhances Bcl-2-Mediated Cell Death
- (2018) Elsie Nolte et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Contribution of the Wnt Pathway to Defining Biology of Glioblastoma
- (2018) Marton Tompa et al. NEUROMOLECULAR MEDICINE
- Papaverine and its derivatives radiosensitize solid tumors by inhibiting mitochondrial metabolism
- (2018) Martin Benej et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Alpha-6 integrin promotes radioresistance of glioblastoma by modulating DNA damage response and the transcription factor Zeb1
- (2018) Aline Kowalski-Chauvel et al. Cell Death & Disease
- Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment
- (2018) Kaitlin Graham et al. International Journal of Nanomedicine
- Perfusion MRI in treatment evaluation of glioblastomas: Clinical relevance of current and future techniques
- (2018) Bart R.J. van Dijken et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Markers of Mitochondrial Metabolism in Tumor Hypoxia, Systemic Inflammation, and Adverse Outcome of Rectal Cancer
- (2018) Paula A. Bousquet et al. Translational Oncology
- Glioblastoma: Microenvironment and Niche Concept
- (2018) Davide Schiffer et al. Cancers
- Enhancing the Radiation Response in KRAS Mutant Colorectal Cancers Using the c-Met Inhibitor Crizotinib
- (2018) Kyle C. Cuneo et al. Translational Oncology
- Treatment of Gliomas: A Changing Landscape
- (2017) Lia M. Halasz et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
- (2017) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas
- (2017) Priya Kumthekar et al. JOURNAL OF NEURO-ONCOLOGY
- Trans sodium crocetinate with temozolomide and radiation therapy for glioblastoma multiforme
- (2017) John L. Gainer et al. JOURNAL OF NEUROSURGERY
- Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma
- (2017) Toni Rose Jue et al. Journal of Translational Medicine
- Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy Is Regulated by MNK1 and mRNA Translation
- (2017) Jonathan B. Bell et al. MOLECULAR CANCER RESEARCH
- Identification of MEK162 as a Radiosensitizer for the Treatment of Glioblastoma
- (2017) Ravi S. Narayan et al. MOLECULAR CANCER THERAPEUTICS
- MR-guided radiation therapy: transformative technology and its role in the central nervous system
- (2017) Yue Cao et al. NEURO-ONCOLOGY
- Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02
- (2017) Evanthia Galanis et al. NEURO-ONCOLOGY
- A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913
- (2017) Prakash Chinnaiyan et al. NEURO-ONCOLOGY
- Inability of positive phase II clinical trials of investigational treatments to subsequently predict positive phase III clinical trials in glioblastoma
- (2017) Jacob J Mandel et al. NEURO-ONCOLOGY
- Lomustine and Bevacizumab in Progressive Glioblastoma
- (2017) Wolfgang Wick et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral complications at 6 months after radiation therapy for head and neck cancer
- (2017) RV Lalla et al. ORAL DISEASES
- PAF promotes stemness and radioresistance of glioma stem cells
- (2017) Derrick Sek Tong Ong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sparing of normal tissues with volumetric arc radiation therapy for glioblastoma: single institution clinical experience
- (2017) Tina Marie Briere et al. Radiation Oncology
- Targeting WNT Signaling for Multifaceted Glioblastoma Therapy
- (2017) Matthew McCord et al. Frontiers in Cellular Neuroscience
- Radioresistance of mesenchymal glioblastoma initiating cells correlates with patient outcome and is associated with activation of inflammatory program
- (2017) Elisabetta Stanzani et al. Oncotarget
- A molecular view of the radioresistance of gliomas
- (2017) Xuetao Han et al. Oncotarget
- Repositioning chlorpromazine for treating chemoresistant glioma through the inhibition of cytochrome c oxidase bearing the COX4-1 regulatory subunit
- (2017) Claudia R. Oliva et al. Oncotarget
- Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation
- (2017) Andrea E. Calvert et al. Cell Reports
- MicroRNA in Glioblastoma: An Overview
- (2017) Barbara Banelli et al. International Journal of Genomics
- Cycling hypoxia: A key feature of the tumor microenvironment
- (2016) Carine Michiels et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Chloroquine, an autophagy inhibitor, potentiates the radiosensitivity of glioma initiating cells by inhibiting autophagy and activating apoptosis
- (2016) Hongxing Ye et al. BMC Neurology
- Knockdown of Cathepsin L promotes radiosensitivity of glioma stem cells both in vivo and in vitro
- (2016) Wenjuan Wang et al. CANCER LETTERS
- Glioblastoma Therapy Can Be Augmented by Targeting IDH1-Mediated NADPH Biosynthesis
- (2016) Daniel R. Wahl et al. CANCER RESEARCH
- LRIGs: A Prognostically Significant Family with Emerging Therapeutic Competence against Cancers
- (2016) Uzma Malik et al. CURRENT CANCER DRUG TARGETS
- RRx-001, A novel dinitroazetidine radiosensitizer
- (2016) Bryan Oronsky et al. INVESTIGATIONAL NEW DRUGS
- Identification of Small Molecule Inhibitors of Human CytochromecOxidase That Target Chemoresistant Glioma Cells
- (2016) Claudia R. Oliva et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting autophagy to sensitive glioma to temozolomide treatment
- (2016) Yuanliang Yan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
- (2016) Yan Michael Li et al. JOURNAL OF NEUROSURGERY
- The impact of hypoxia and its modification of the outcome of radiotherapy
- (2016) Michael R. Horsman et al. JOURNAL OF RADIATION RESEARCH
- Whole-brain spectroscopic MRI biomarkers identify infiltrating margins in glioblastoma patients
- (2016) James S. Cordova et al. NEURO-ONCOLOGY
- Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma—results from the DIRECTOR trial
- (2016) Bogdana Suchorska et al. NEURO-ONCOLOGY
- Targeting hexokinase 2 enhances response to radio-chemotherapy in glioblastoma
- (2016) Alenoush Vartanian et al. Oncotarget
- FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells
- (2016) Uday B. Maachani et al. Oncotarget
- Glioblastoma Stem Cells Microenvironment: The Paracrine Roles of the Niche in Drug and Radioresistance
- (2016) Alessia Fidoamore et al. Stem Cells International
- STAT3 Serine 727 Phosphorylation: A Relevant Target to Radiosensitize Human Glioblastoma
- (2015) Zangbéwendé Guy Ouédraogo et al. BRAIN PATHOLOGY
- Mechanistic Rationale to Target PTEN-Deficient Tumor Cells with Inhibitors of the DNA Damage Response Kinase ATM
- (2015) Nuala McCabe et al. CANCER RESEARCH
- A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients
- (2015) E. Q. Lee et al. CLINICAL CANCER RESEARCH
- A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma
- (2015) Manfred Westphal et al. EUROPEAN JOURNAL OF CANCER
- Phase 1/2 Trials of Temozolomide, Motexafin Gadolinium, and 60-Gy Fractionated Radiation for Newly Diagnosed Supratentorial Glioblastoma Multiforme: Final Results of RTOG 0513
- (2015) David G. Brachman et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma
- (2015) Andra V. Krauze et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma
- (2015) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- WNT signaling in glioblastoma and therapeutic opportunities
- (2015) Yeri Lee et al. LABORATORY INVESTIGATION
- Radiosensitization of Primary Human Glioblastoma Stem-like Cells with Low-Dose AKT Inhibition
- (2015) M. Mehta et al. MOLECULAR CANCER THERAPEUTICS
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012
- (2015) Quinn T. Ostrom et al. NEURO-ONCOLOGY
- Molecular Genetics of Glioblastomas
- (2015) Ilana Zalcberg Renault et al. NEUROIMAGING CLINICS OF NORTH AMERICA
- Microenvironmental Modulation of Decorin and Lumican in Temozolomide-Resistant Glioblastoma and Neuroblastoma Cancer Stem-Like Cells
- (2015) Cristiano Farace et al. PLoS One
- Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity
- (2015) Mona Meyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Wnt/β-catenin pathway involvement in ionizing radiation-induced invasion of U87 glioblastoma cells
- (2015) Zhen Dong et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Nuclear-encoded cytochrome c oxidase subunit 4 regulates BMI1 expression and determines proliferative capacity of high-grade gliomas
- (2015) Claudia R Oliva et al. Oncotarget
- IDH mutation and MGMT promoter methylation in glioblastoma: results of a prospective registry
- (2015) Pei Yang et al. Oncotarget
- The Evidence of Glioblastoma Heterogeneity
- (2015) Akio Soeda et al. Scientific Reports
- The Microenvironment in Gliomas: Phenotypic Expressions
- (2015) Davide Schiffer et al. Cancers
- FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2
- (2015) Yeri Lee et al. PLoS One
- Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas
- (2015) Yuchen Jiao et al. Oncotarget
- Analysis of Cancer Metabolism by Imaging Hyperpolarized Nuclei: Prospects for Translation to Clinical Research
- (2015) John Kurhanewicz et al. NEOPLASIA
- The Brain Microenvironment Preferentially Enhances the Radioresistance of CD133+ Glioblastoma Stem-like Cells
- (2015) Muhammad Jamal et al. NEOPLASIA
- Advanced Magnetic Resonance Imaging of the Physical Processes in Human Glioblastoma
- (2014) Jayashree Kalpathy-Cramer et al. CANCER RESEARCH
- Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells
- (2014) Mario L. Suvà et al. CELL
- miR-221/222 Confers Radioresistance in Glioblastoma Cells Through Activating Akt Independent of PTEN Status
- (2014) W. Li et al. CURRENT MOLECULAR MEDICINE
- Hypoxia sustains glioblastoma radioresistance through ERKs/DNA-PKcs/HIF-1α functional interplay
- (2014) FRANCESCO MARAMPON et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
- (2014) Roger Stupp et al. LANCET ONCOLOGY
- A Functional Screen Identifies miRs That Induce Radioresistance in Glioblastomas
- (2014) P. Moskwa et al. MOLECULAR CANCER RESEARCH
- Abrogation of radioresistance in glioblastoma stem-like cells by inhibition of ATM kinase
- (2014) Ross Carruthers et al. Molecular Oncology
- Cisplatin-tethered gold nanospheres for multimodal chemo-radiotherapy of glioblastoma
- (2014) Sonali Setua et al. Nanoscale
- The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone
- (2014) Remco J. Molenaar et al. NEURO-ONCOLOGY
- Sulfasalazine and temozolomide with radiation therapy for newly diagnosed glioblastoma
- (2014) Satoru Takeuchi et al. NEUROLOGY INDIA
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
- (2014) Olivier L. Chinot et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNMT-dependent suppression of microRNA regulates the induction of GBM tumor-propagating phenotype by Oct4 and Sox2
- (2014) H Lopez-Bertoni et al. ONCOGENE
- History and Evolution of Brain Tumor Imaging: Insights throughRadiology
- (2014) Mauricio Castillo RADIOLOGY
- Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
- (2014) A. P. Patel et al. SCIENCE
- Novel strategies in glioblastoma surgery aim at safe, supra-maximum resection in conjunction with local therapies
- (2014) John G. Wolbers Chinese Journal of Cancer
- Cancer Stem Cells and Their Mechanism of Chemo-Radiation Resistance
- (2014) Yonghyun Kim et al. International Journal of Stem Cells
- Molecular targets and mechanisms of radiosensitization using DNA damage response pathways
- (2013) David R Raleigh et al. Future Oncology
- Hypoxia Enhances Stemness of Cancer Stem Cells in Glioblastoma: An In Vitro Study
- (2013) Pengcheng Li et al. International Journal of Medical Sciences
- Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma
- (2013) Tracy T. Batchelor et al. JOURNAL OF CLINICAL ONCOLOGY
- Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
- (2013) Mark R. Gilbert et al. JOURNAL OF CLINICAL ONCOLOGY
- miR-124 radiosensitizes human glioma cells by targeting CDK4
- (2013) Xubin Deng et al. JOURNAL OF NEURO-ONCOLOGY
- Mitochondrial protein ATPase family, AAA domain containing 3A correlates with radioresistance in glioblastoma
- (2013) W.-C. You et al. NEURO-ONCOLOGY
- IDH1/2 mutations target a key hallmark of cancer by deregulating cellular metabolism in glioma
- (2013) Chunzhi Zhang et al. NEURO-ONCOLOGY
- Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
- (2013) A. Sottoriva et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Personalized treatment strategies in glioblastoma: MGMT promoter methylation status
- (2013) Niklas Thon et al. OncoTargets and Therapy
- Novel functions of FoxM1: from molecular mechanisms to cancer therapy
- (2013) Mónica Alvarez-Fernández et al. Frontiers in Oncology
- Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: Potential role of hypoxia
- (2012) Delphine Tamara Marie-Egyptienne et al. CANCER LETTERS
- Cancer and Radiation Therapy: Current Advances and Future Directions
- (2012) Rajamanickam Baskar et al. International Journal of Medical Sciences
- Phase I study of arsenic trioxide and temozolomide in combination with radiation therapy in patients with malignant gliomas
- (2012) Sean A. Grimm et al. JOURNAL OF NEURO-ONCOLOGY
- A Systematic Review of MicroRNA in Glioblastoma Multiforme: Micro-modulators in the Mesenchymal Mode of Migration and Invasion
- (2012) Heidi G. Møller et al. MOLECULAR NEUROBIOLOGY
- A restricted cell population propagates glioblastoma growth after chemotherapy
- (2012) Jian Chen et al. NATURE
- Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass
- (2012) Lou K. Povlsen et al. NATURE CELL BIOLOGY
- Patterns of care and survival for patients with glioblastoma multiforme diagnosed during 2006
- (2012) K. R. Yabroff et al. NEURO-ONCOLOGY
- Essential role of cooperative NF-κB and Stat3 recruitment to ICAM-1 intronic consensus elements in the regulation of radiation-induced invasion and migration in glioma
- (2012) D Kesanakurti et al. ONCOGENE
- Tumor Microenvironment in the Brain
- (2012) Mihaela Lorger Cancers
- Neuroradiology Back to the Future: Brain Imaging
- (2011) E.G. Hoeffner et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- β-catenin and Gli1 are prognostic markers in glioblastoma
- (2011) Marco Rossi et al. CANCER BIOLOGY & THERAPY
- Nonreceptor Tyrosine Kinase BMX Maintains Self-Renewal and Tumorigenic Potential of Glioblastoma Stem Cells by Activating STAT3
- (2011) Olga A. Guryanova et al. CANCER CELL
- FoxM1: A Master Regulator of Tumor Metastasis
- (2011) P. Raychaudhuri et al. CANCER RESEARCH
- Frizzled 4 Regulates Stemness and Invasiveness of Migrating Glioma Cells Established by Serial Intracranial Transplantation
- (2011) X. Jin et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The brain tumor microenvironment
- (2011) Nikki A. Charles et al. GLIA
- Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme
- (2011) Amparo Wolf et al. JOURNAL OF CELL BIOLOGY
- Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis
- (2011) Yi-Ping Yang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- An extent of resection threshold for newly diagnosed glioblastomas
- (2011) Nader Sanai et al. JOURNAL OF NEUROSURGERY
- Annual Report to the Nation on the Status of Cancer, 1975-2007, Featuring Tumors of the Brain and Other Nervous System
- (2011) B. A. Kohler et al. JNCI-Journal of the National Cancer Institute
- Targeting Radiation-Induced G2 Checkpoint Activation with the Wee-1 Inhibitor MK-1775 in Glioblastoma Cell Lines
- (2011) B. Sarcar et al. MOLECULAR CANCER THERAPEUTICS
- Radioresistance of glioma stem cells: Intrinsic characteristic or property of the ‘microenvironment-stem cell unit’?
- (2011) Mariella Mannino et al. Molecular Oncology
- A phase I/II trial of enzastaurin in patients with recurrent high-grade gliomas
- (2011) Teri N. Kreisl et al. NEURO-ONCOLOGY
- Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma
- (2011) N. Butowski et al. NEURO-ONCOLOGY
- Acquisition of Chemoresistance in Gliomas Is Associated with Increased Mitochondrial Coupling and Decreased ROS Production
- (2011) Claudia R. Oliva et al. PLoS One
- Increased betulinic acid induced cytotoxicity and radiosensitivity in glioma cells under hypoxic conditions
- (2011) Matthias Bache et al. Radiation Oncology
- TP53 induced glycolysis and apoptosis regulator (TIGAR) knockdown results in radiosensitization of glioma cells
- (2011) Miguel A. Peña-Rico et al. RADIOTHERAPY AND ONCOLOGY
- Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas
- (2010) Christian Hartmann et al. ACTA NEUROPATHOLOGICA
- Regulation of mRNA Translation and Stability by microRNAs
- (2010) Marc Robert Fabian et al. Annual Review of Biochemistry
- Pro-survival AKT and ERK signaling from EGFR and mutant EGFRvIII enhances DNA double-strand break repair in human glioma cells
- (2010) Sarah E. Golding et al. CANCER BIOLOGY & THERAPY
- TGF-β Receptor Inhibitors Target the CD44high/Id1high Glioma-Initiating Cell Population in Human Glioblastoma
- (2010) Judit Anido et al. CANCER CELL
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- CD44 Attenuates Activation of the Hippo Signaling Pathway and Is a Prime Therapeutic Target for Glioblastoma
- (2010) Y. Xu et al. CANCER RESEARCH
- The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype
- (2010) John M. Heddleston et al. CELL CYCLE
- Integrin Alpha 6 Regulates Glioblastoma Stem Cells
- (2010) Justin D. Lathia et al. Cell Stem Cell
- Molecular imaging of cancer: MR spectroscopy and beyond
- (2010) K. Pinker et al. EUROPEAN JOURNAL OF RADIOLOGY
- Improved Intratumoral Oxygenation Through Vascular Normalization Increases Glioma Sensitivity to Ionizing Radiation
- (2010) Mackenzie C. McGee et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Acquisition of Temozolomide Chemoresistance in Gliomas Leads to Remodeling of Mitochondrial Electron Transport Chain
- (2010) Claudia R. Oliva et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hypofractionated Stereotactic Radiation Therapy: An Effective Therapy for Recurrent High-Grade Gliomas
- (2010) Shannon E. Fogh et al. JOURNAL OF CLINICAL ONCOLOGY
- BMI1 Confers Radioresistance to Normal and Cancerous Neural Stem Cells through Recruitment of the DNA Damage Response Machinery
- (2010) S. Facchino et al. JOURNAL OF NEUROSCIENCE
- PET/MRI: Paving the Way for the Next Generation of Clinical Multimodality Imaging Applications
- (2010) B. J. Pichler et al. JOURNAL OF NUCLEAR MEDICINE
- Cycling hypoxia increases U87 glioma cell radioresistance via ROS induced higher and long-term HIF-1 signal transduction activity
- (2010) Hsieh ONCOLOGY REPORTS
- Akt/protein kinase B overexpression as an accurate prognostic marker in adult diffuse astrocytoma
- (2009) Tomoo Matsutani et al. ACTA NEUROCHIRURGICA
- Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells
- (2009) Zhizhong Li et al. CANCER CELL
- Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme
- (2009) Giulio Metro et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- EGFRvIII and DNA Double-Strand Break Repair: A Molecular Mechanism for Radioresistance in Glioblastoma
- (2009) B. Mukherjee et al. CANCER RESEARCH
- SnapShot: MicroRNAs in Cancer
- (2009) Riccardo Spizzo et al. CELL
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- SSEA-1 Is an Enrichment Marker for Tumor-Initiating Cells in Human Glioblastoma
- (2009) Myung Jin Son et al. Cell Stem Cell
- Notch signalling in cancer stem cells
- (2009) Victoria Bolós et al. Clinical & Translational Oncology
- IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas
- (2009) S. Nobusawa et al. CLINICAL CANCER RESEARCH
- Increase in thiol oxidative stress via glutathione reductase inhibition as a novel approach to enhance cancer sensitivity to X-ray irradiation
- (2009) Yong Zhao et al. FREE RADICAL BIOLOGY AND MEDICINE
- Radiosensitizing Effects of Temozolomide Observed in vivo only in a Subset of O6-Methylguanine-DNA Methyltransferase Methylated Glioblastoma Multiforme Xenografts
- (2009) Brett L. Carlson et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A Comparison of Volumetric Modulated Arc Therapy and Conventional Intensity-Modulated Radiotherapy for Frontal and Temporal High-Grade Gliomas
- (2009) Richard Shaffer et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Talampanel With Standard Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma: A Multicenter Phase II Trial
- (2009) Stuart A. Grossman et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radiation-induced Akt activation modulates radioresistance in human glioblastoma cells
- (2009) Hui-Fang Li et al. Radiation Oncology
- The Increasing Complexity of the Cancer Stem Cell Paradigm
- (2009) J. M. Rosen et al. SCIENCE
- Notch Promotes Radioresistance of Glioma Stem Cells
- (2009) Jialiang Wang et al. STEM CELLS
- STAT3 Is Required for Proliferation and Maintenance of Multipotency in Glioblastoma Stem Cells
- (2009) Maureen M. Sherry et al. STEM CELLS
- Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizer
- (2008) J. Sigmond et al. ANNALS OF ONCOLOGY
- Targeting of the Bmi-1 Oncogene/Stem Cell Renewal Factor by MicroRNA-128 Inhibits Glioma Proliferation and Self-Renewal
- (2008) J. Godlewski et al. CANCER RESEARCH
- Prognostic relevance of SOCS3 hypermethylation in patients with glioblastoma multiforme
- (2008) Maurizio Martini et al. INTERNATIONAL JOURNAL OF CANCER
- Phase I Three-Dimensional Conformal Radiation Dose Escalation Study in Newly Diagnosed Glioblastoma: Radiation Therapy Oncology Group Trial 98-03
- (2008) Christina Tsien et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
- (2008) Michael D. Prados et al. JOURNAL OF CLINICAL ONCOLOGY
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- IDENTIFICATION OF A2B5+CD133− TUMOR-INITIATING CELLS IN ADULT HUMAN GLIOMAS
- (2008) Alfred T. Ogden et al. NEUROSURGERY
- Simultaneous MR/PET Imaging of the Human Brain: Feasibility Study
- (2008) Heinz-Peter W. Schlemmer et al. RADIOLOGY
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started